SK

Sushil Kumar

Director Director DIN 08283635
DIN 08283635 First appointment Nov 2018 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushil Kumar

Data last updated:

Sushil Kumar was a Director at Winthrop Pharmaceuticals Private Limited (2018–2024) and Director at Orva Hospital Private Limited (from 2019). The companies operate in Trading.

DIN 08283635
Primary Designation Director
Industry Trading
First Appointment 21 Nov 2018
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20182015₹9.5 Lakh (FY 2024)Active
Orva Hospital Private Limited U85110DL2019PTC350926
Director04 Jun 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orva Hospital Private Limited
Winthrop Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Kumar

Sushil Kumar was first appointed on 21 Nov 2018 as Director at Winthrop Pharmaceuticals Private Limited. The most recent appointment on record is 04 Jun 2019 at Orva Hospital Private Limited.

Sushil Kumar held 2 earlier board appointments: Winthrop Pharmaceuticals Private Limited (Director, 21 Nov 2018 to 16 Nov 2024); Orva Hospital Private Limited (Director, from 04 Jun 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available